Data for (Study ST000344)

(Analysis AN000557)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
1_CE (22:1) iSTD 1.0523 0.9477
1_Ceramide C17 iSTD 1.0921 0.9079
1_Cholesterol d7 iSTD 1.1445 0.8555
1_CUDA (pos) iSTD 1.0404 0.9596
1_DG (12:0/12:0/0:0) iSTD 1.3734 0.6266
1_DG (18:1/2:0/0:0) iSTD 1.3338 0.6662
1_LPC (17:0) iSTD 1.1741 0.8259
1_LPE (17:1) iSTD 1.1187 0.8813
1_MG (17:0/0:0/0:0) iSTD 1.1174 0.8826
1_PC (25:0) iSTD 1.1683 0.8317
1_PE (17:0/17:0) iSTD 1.1345 0.8655
1_SM (d35:1) iSTD 1.1721 0.8279
1_Sphingosine (d17:1) iSTD 1.1502 0.8498
1_TG (17:0/17:1/17:0)-d5 iSTD 1.2622 0.7378
Ceramide (d40:1) 1.2898 0.7102
Ceramide (d42:1) 1.2795 0.7205
Ceramide (d42:2) 1.1557 0.8443
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0) 1.0755 0.9245
GlcCer (d40:1) 1.1964 0.8036
GlcCer (d42:1) 1.1795 0.8205
GlcCer (d42:2) 1.0141 0.9859
Lactosylceramide (d18:1/24:1(15Z)) 1.1379 0.8621
PC (28:0) 1.2117 0.7883
PC (30:0) 1.1374 0.8626
PC (30:1) 1.1670 0.8330
PC (32:1) 1.1415 0.8585
PC (32:3) 1.1534 0.8466
PC (36:1) 1.1467 0.8533
PC (38:2) 0.9915 1.0085
PC (38:4) B 1.0989 0.9011
PC (40:1) 1.1152 0.8848
PC (40:2) 1.0267 0.9733
PC (42:1) 1.1187 0.8813
PC (42:2) 1.0428 0.9572
PC (p-34:3) or PC (o-34:4) 1.2856 0.7144
PC (p-36:0) or PC (o-36:1) 1.1413 0.8587
PC (p-36:1) or PC (o-36:2) 1.0083 0.9917
PC (p-36:3) or PC (o-36:4) 1.1289 0.8711
PE (32:1) 1.1642 0.8358
PE (34:1) 1.1431 0.8569
PE (34:2) 1.1310 0.8690
PE (36:1) 1.1868 0.8132
PE (36:2) 0.8669 1.1331
PE (p-32:1) oe PE (o-32:2) 1.2122 0.7878
PE (p-34:1) or PE (o-34:2) 1.1570 0.8430
PE (p-36:1) or PE (o-36:2) 1.1793 0.8207
PE (p-36:2) or PE (o-36:3) 1.0578 0.9422
SM (d34:0) 1.1437 0.8563
SM (d40:0) 1.2969 0.7031
SM (d42:0) 1.3102 0.6898
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Treatment:Control
F2Treatment:Lipid Supplement
  logo